Welcome to LookChem.com Sign In|Join Free
  • or
4-Hydroxy-3-nitroquinoline-6-boronic acid pinacol ester is a complex organic compound with the molecular formula C14H16BNO6. It is a derivative of quinoline, a heterocyclic compound with a benzene ring fused to a pyridine ring. The molecule features a hydroxyl group at the 4-position, a nitro group at the 3-position, and a boronic acid group at the 6-position. The pinacol ester group is attached to the boronic acid, which enhances the stability and solubility of the compound. This chemical is often used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly in the preparation of boron-containing heterocycles. Its unique structure allows for versatile chemical reactions, making it a valuable building block in organic synthesis.

1201646-88-9

Post Buying Request

1201646-88-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1201646-88-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1201646-88-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,6,4 and 6 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1201646-88:
(9*1)+(8*2)+(7*0)+(6*1)+(5*6)+(4*4)+(3*6)+(2*8)+(1*8)=119
119 % 10 = 9
So 1201646-88-9 is a valid CAS Registry Number.

1201646-88-9Relevant academic research and scientific papers

PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS

-

, (2010/01/12)

Provided are compounds according to Formula (I), or stereoisomer, prodrug, polymorph, or pharmaceutically acceptable salt forms thereof, wherein X, Y, R1, R6 , R7, and R8 are as defined, which compounds are effective inhibitors of PI3-kinase and/or other medically and clinically relevant kinases. Also provided are pharmaceutical compositions and methods of using the compounds and compositions as PB -kinase and kinase inhibitors. More particularly, the compounds of the invention provide treatments and therapeutics for human diseases regulated by, or associated with, the activity of, PI3-kinases and/or protein kinases, or mutant or variant forms thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1201646-88-9